Moghimi-Dehkordi B, Safaee A, Zali MR. Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2009;15:18–23.
Article
Google Scholar
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
Article
CAS
PubMed
Google Scholar
Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48.
Article
PubMed Central
Google Scholar
Elghali MA, Gouader A, Bouriga R, Mahjoub M, Jarrar MS, Ziadi S, et al. Gastric adenocarcinomas in Central Tunisia: evolution specificities through two decades and relation with helicobacter pylori. Oncology. 2018;95:121–8.
Article
PubMed
Google Scholar
Article medicale Tunisie, Article medicale Epidémiologie , Cancer colorectal , Adénocarcinome mucineux , Immunohistochimie , Galectine-3. http://www.latunisiemedicale.com/article-medicale-tunisie_1236_fr. Accessed 9 Oct 2019.
Gonzalez-Pons M, Cruz-Correa M. Colorectal cancer biomarkers: where are we now? Biomed Res Int. 2015;2015. https://doi.org/10.1155/2015/149014.
Park SM, Lee J, Kim YA, Chang YJ, Kim MS, Shim YM, et al. Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea. BMC Cancer. 2017;17:600.
Article
PubMed
PubMed Central
Google Scholar
Matsuoka T, Yashiro M. Biomarkers of gastric cancer: current topics and future perspective. World J Gastroenterol. 2018;24:2818–32.
Article
PubMed
PubMed Central
Google Scholar
Iorio J, Meattini I, Bianchi S, Bernini M, Maragna V, Dominici L, et al. hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. Cancer Cell Int. 2018;18. https://doi.org/10.1186/s12935-018-0592-1.
Huang X, Jan LY. Targeting potassium channels in cancer. J Cell Biol. 2014;206:151–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Serrano-Novillo C, Capera J, Colomer-Molera M, Condom E, Ferreres JC, Felipe A. Implication of voltage-gated potassium channels in neoplastic cell proliferation. Cancers. 2019;11. https://doi.org/10.3390/cancers11030287.
Rangaraju S, Chi V, Pennington MW, Chandy KG. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets. 2009;13:909–24.
Article
CAS
PubMed
Google Scholar
Kunzelmann K. Ion channels and cancer. J Membr Biol. 2005;205:159–73.
Article
CAS
PubMed
Google Scholar
Liu M, Li S, Du M, Chu H, Wang M, Zhang Z. Novel CpG-SNPs in the gastric acid secretion pathway GNAI3 and susceptibility to gastric cancer. Gene. 2020;736:144447.
Article
CAS
PubMed
Google Scholar
Brainard AM, Korovkina VP, England SK. Potassium channels and uterine function. Semin Cell Dev Biol. 2007;18:332–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, Bubendorf L, et al. Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2007;13:824–31.
Article
CAS
Google Scholar
Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C, et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. Radiology. 2007;245:176–85.
Article
PubMed
Google Scholar
Barbirou M, Sghaier I, Bedoui S, Ben Abderrazek R, Kraiem H, Farah A, et al. KCNB1 gene polymorphisms and related indel as predictor biomarkers of treatment response for colorectal cancer - toward a personalized medicine. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2020;42:1010428320925237.
Article
CAS
Google Scholar
Szabò I, Bock J, Jekle A, Soddemann M, Adams C, Lang F, et al. A novel potassium channel in lymphocyte mitochondria. J Biol Chem. 2005;280:12790–8.
Article
PubMed
Google Scholar
Zhu J, Yan J, Thornhill WB. The Kv1.3 potassium channel is localized to the cis-Golgi and Kv1.6 is localized to the endoplasmic reticulum in rat astrocytes. FEBS J. 2014;281:3433–45.
Article
CAS
PubMed
Google Scholar
Jang SH, Byun JK, Jeon W-I, Choi SY, Park J, Lee BH, et al. Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3. J Biol Chem. 2015;290:12547–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Toro L, Li M, Zhang Z, Singh H, Wu Y, Stefani E. MaxiK channel and cell signalling., MaxiK channel and cell signalling. Pflugers Arch Eur J Physiol Pflugers Arch Eur J Physiol. 2014;466:875–86.
Article
CAS
Google Scholar
Turgut Cosan D, Soyocak A, Oner C. Inhibition of voltage-gated potassium channels affect expressions of miR-126 and miR-126* in breast cancer cell lines. Bratisl Lek Listy. 2020;121:111–6.
CAS
PubMed
Google Scholar
Checchetto V, Teardo E, Carraretto L, Leanza L, Szabo I. Physiology of intracellular potassium channels: a unifying role as mediators of counterion fluxes? Biochim Biophys Acta. 1857;2016:1258–66.
Google Scholar
Bachmann M, Costa R, Peruzzo R, Prosdocimi E, Checchetto V, Leanza L. Targeting mitochondrial ion channels to fight cancer. Int J Mol Sci. 2018;19. https://doi.org/10.3390/ijms19072060.
Lan M, Shi Y, Han Z, Hao Z, Pan Y, Liu N, et al. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol Ther. 2005;4:1342–7.
Article
CAS
PubMed
Google Scholar
Lee J-H, Park J-W, Byun JK, Kim HK, Ryu PD, Lee SY, et al. Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells. Oncotarget. 2015;6:8132–43.
Article
PubMed
PubMed Central
Google Scholar
Zhang F, Bian Y, Huang L, Fan W. Association between connexin 40 and potassium voltage-gated channel subfamily A member 5 expression in the atrial myocytes of patients with atrial fibrillation. Exp Ther Med. 2017;14:5170–6.
CAS
PubMed
PubMed Central
Google Scholar
Corona C, Pasini S, Liu J, Amar F, Greene LA, Shelanski ML. Activating transcription factor 4 (ATF4) regulates neuronal activity by controlling GABABR trafficking. J Neurosci. 2018;38:6102–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lastraioli E, Bencini L, Bianchini E, Romoli MR, Crociani O, Giommoni E, et al. hERG1 channels and Glut-1 as independent prognostic indicators of worse outcome in stage I and II colorectal cancer: a pilot study. Transl Oncol. 2012;5:105–12.
Article
PubMed
PubMed Central
Google Scholar
Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathol. 1987;8:138–40.
CAS
Google Scholar
Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue – a review. Diagn Pathol. 2014;9. https://doi.org/10.1186/s13000-014-0221-9.
Spitzer NC. Electrical activity in early neuronal development. Nature. 2006;444:707–12.
Article
CAS
PubMed
Google Scholar
Ryland KE, Hawkins AG, Weisenberger DJ, Punj V, Borinstein SC, Laird PW, et al. Promoter methylation analysis reveals that KCNA5 ion channel silencing supports Ewing sarcoma cell proliferation. Mol Cancer Res MCR. 2016;14:26–34.
Article
CAS
PubMed
Google Scholar
Than BLN, Goos JACM, Sarver AL, O’Sullivan MG, Rod A, Starr TK, et al. The role of KCNQ1 in mouse and human gastrointestinal cancers. Oncogene. 2014;33:3861–8.
Article
CAS
PubMed
Google Scholar
Bielanska J, Hernández-Losa J, Pérez-Verdaguer M, Moline T, Somoza R, Ramón Y, Cajal S, et al. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr Cancer Drug Targets. 2009;9:904–14.
Article
CAS
PubMed
Google Scholar
Vicente R, Coma M, Busquets S, Moore-Carrasco R, López-Soriano FJ, Argilés JM, et al. The systemic inflammatory response is involved in the regulation of K(+) channel expression in brain via TNF-alpha-dependent and -independent pathways. FEBS Lett. 2004;572:189–94.
Article
CAS
PubMed
Google Scholar
Fox PD, Haberkorn CJ, Akin EJ, Seel PJ, Krapf D, Tamkun MM. Induction of stable ER–plasma-membrane junctions by Kv2.1 potassium channels. J Cell Sci. 2015;128:2096–105.
Article
CAS
PubMed
PubMed Central
Google Scholar
Panyi G, Bagdány M, Bodnár A, Vámosi G, Szentesi G, Jenei A, et al. Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc Natl Acad Sci U S A. 2003;100:2592–7.
Article
CAS
PubMed
PubMed Central
Google Scholar